US Patent Issued to AbbVie Manufacturing Management UnLtd. on Oct. 7 for "Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotin" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,951, issued on Oct. 7, was assigned to AbbVie Manufacturing Management UnLtd. Co. (Dublin).

"Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotin" was invented by Janet Yikai Jin (Foster City, Calif.), Philip B. Komarnitsky (Chestnut Hill, Mass.), Mirella Lazarov (Simi Valley, Calif.) and Anita Reddy (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides improved methods of treatment of NSCLC cancers using telisotuzumab vedotin."

The patent was filed on April 6, 2022, under Application No. 17/714,724.

*For further information, including images, charts and tables, please visit:...